Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-089-2 | CAS number: 629-40-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 986
- Report date:
- 1986
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Suberonitrile
- EC Number:
- 211-089-2
- EC Name:
- Suberonitrile
- Cas Number:
- 629-40-3
- Molecular formula:
- C8H12N2
- IUPAC Name:
- octanedinitrile
- Details on test material:
- - Name of test substance (as cited in study report): Korksaeure Dinitril Roh Ber. 100%
- Analytical purity: > 90%
- Substance No.: 86/199
- Physical state: liquid
- Stability: stable
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Additional information on strain: KFM-Han. Wistar (outbred, SPF-Quality)
- Source: Kleintierfarm Madoerin AG, Fuellingsdorf; Switzerland
- Age at study initiation: 9 - 11 weeks
- Weight at study initiation: 185 - 231 g (males); 175 - 210 g (females)
- Fasting period before study: 12 - 18 h
- Housing: 5/cage; Makrolon type-3 cages with standard softwool bedding
- Diet: Pelleted standard Kliba 343; Batch 50/86 rat maintenance diet (Klingentalmuehle AG, Kaiseraugust, Switzerland); ad libitum
- Water: tap water; ad libitum
- Acclimation period: at least one week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 40 - 70
- Air changes (per hr): 10 - 15
- Photoperiod (hrs dark / hrs light): 12 / 12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Remarks:
- 4%
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 20% or 100%
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw - Doses:
- 100, 300, 1000 and 5000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: four times during day 1 (day of treatment) and daily during days 2 - 15
- Frequency of weighing: day 1 (before administration), 8 and 15
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, macroscopic findings - Statistics:
- The Logit-Model was applied to estimate the toxicity value. Additionally, the 90, 95 and 99% confidence intervals for the toxicity for each sex and the slope of the dose response line were estimated.
Results and discussion
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 300 - < 1 000 mg/kg bw
- Based on:
- test mat.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 396 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 269 - <= 686
- Remarks on result:
- other: original value from study report
- Mortality:
- - 100 mg/kg bw: 0/10
- 300 mg/kg bw: 2/10
- 1000 mg/kg bw: 10/10
- 5000 mg/kg bw: 10/10 - Clinical signs:
- other: - 100 mg/kg bw: sedation, curved body position, ruffled fur - 300 mg/kg bw: sedation, dyspnoea, ataxia, curved body postion, latero-abdominal position (females), ruffled fur - 1000 mg/kg bw: sedation, somnolence, rales, dyspnoea (males), ataxia, latero-ab
- Gross pathology:
- The following macroscopic organ changes were observed:
- 100 mg/kg bw: (sacrificed) lung: red foci, diameter 1mm (2/10); reddish discoloured (1/10)
- 300 mg/kg bw: (dead) cannibalism: abdominal region (2/10); (sacrificed) lung: apical lobe, black discoloured (3/10)
- 1000 mg/kg bw: (dead) lung: left lobe red foci, induration (2/10); intestines: yellowish, hard contents (1/10); red to brown contents (3/10)
- 5000 mg/kg bw: (dead) lung: dark-red (5/10); red foci (1/10); left lobe dark-red (1/10); jejenum: yellowish contents (1/10)
Any other information on results incl. tables
Table 1. Table for acute oral toxicity (mortality)
Dose |
Toxicological results* |
Time of death |
Mortality (%) |
Males |
|||
100 |
0/5 |
--- |
0 |
300 |
1/5 |
24H |
20 |
1000 |
5/5 |
3H – 5H |
100 |
5000 |
5/5 |
1H – 2H |
100 |
LD50 (males) = 392 mg/kg bw |
|||
Females |
|||
100 |
0/5 |
-- |
0 |
300 |
1/5 |
24H |
20 |
1000 |
5/5 |
5H and 3D |
100 |
5000 |
5/5 |
1H and 3H |
100 |
LD50 (females) = 392 mg/kg bw |
|||
LD50 = 396 mg/kg bw |
* first number = number of dead animals
second number = number of animals used
Table 2: Acute oral toxicity: Clinical signs
Dose (mg/kg bw) |
100 |
300 |
1000 |
5000 |
||||
M |
F |
M |
F |
M |
F |
M |
F |
|
Sedation |
2H – 4D |
2H – 4D |
1H – 2D |
1H – 2D |
1H – 3H |
n.d. |
n.d. |
n.d. |
Curved body position |
2H – 4D |
2H – 4D |
1H – 5H |
1H – 5H |
1H – 3H |
n.d. |
n.d. |
n.d. |
Ruffled fur |
2H – 4D |
2H – 4D |
1H – 2D |
1H – 2D |
1H – 3H |
n.d. |
n.d. |
n.d. |
Dyspnoea |
|
|
2H – 5H |
1H – 5H |
2H – 3H |
n.d. |
n.d. |
n.d. |
Ataxia |
|
|
2H – 5H |
1H – 5H |
1H – 3H |
n.d. |
n.d. |
n.d. |
Latero-abdom. position |
|
|
|
2H |
1H – 3H |
n.d. |
n.d. |
n.d. |
Rales |
|
|
|
|
3H |
n.d. |
n.d. |
n.d. |
Spasms |
|
|
|
|
3H |
n.d. |
n.d. |
n.d. |
Tremor |
|
|
|
|
2H – 3H |
n.d. |
n.d. |
n.d. |
Somnolence |
|
|
|
|
1H – 3H |
n.d. |
n.d. |
n.d. |
H = hour; D = hour
n.d. = no data (missing pages in study report)
Applicant's summary and conclusion
- Interpretation of results:
- harmful
- Remarks:
- Migrated information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.